BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 975 filers reported holding BAXTER INTL INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $289,989 | +14.3% | 6,365 | +0.3% | 0.07% | +4.5% |
Q1 2023 | $253,673 | -36.4% | 6,345 | -19.0% | 0.07% | -46.0% |
Q4 2022 | $399,095 | -11.7% | 7,830 | -2.5% | 0.12% | -12.1% |
Q3 2022 | $452,000 | -13.4% | 8,030 | -1.2% | 0.14% | -12.4% |
Q2 2022 | $522,000 | -17.7% | 8,129 | -0.6% | 0.16% | +0.6% |
Q1 2022 | $634,000 | -12.7% | 8,182 | -3.2% | 0.16% | -3.6% |
Q4 2021 | $726,000 | -0.5% | 8,452 | -6.9% | 0.17% | -6.2% |
Q3 2021 | $730,000 | -0.1% | 9,082 | 0.0% | 0.18% | +2.3% |
Q2 2021 | $731,000 | -4.6% | 9,082 | 0.0% | 0.17% | -14.4% |
Q1 2021 | $766,000 | +5.1% | 9,082 | 0.0% | 0.20% | -12.2% |
Q4 2020 | $729,000 | -6.5% | 9,082 | -6.4% | 0.23% | -19.0% |
Q3 2020 | $780,000 | -12.3% | 9,702 | -4.7% | 0.28% | -15.0% |
Q2 2020 | $889,000 | +7.5% | 10,182 | 0.0% | 0.33% | -12.1% |
Q1 2020 | $827,000 | -51.4% | 10,182 | -50.0% | 0.38% | +19.1% |
Q4 2019 | $1,702,000 | +88.3% | 20,364 | +97.1% | 0.32% | -21.4% |
Q3 2019 | $904,000 | +1.9% | 10,332 | -4.6% | 0.41% | +0.2% |
Q2 2019 | $887,000 | -5.0% | 10,832 | -5.8% | 0.40% | -10.0% |
Q1 2019 | $934,000 | +26.2% | 11,493 | +2.2% | 0.45% | -1.1% |
Q4 2018 | $740,000 | – | 11,247 | – | 0.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |